抄録
The results of clinical studies on MOM for oral use, performed at 22 institutes in this country, are summarized in this protocol. The conclusions obtained is as follows:
1) Clinical efficacy of MOM oral administration was evaluated in 113 patients with oral infectious disease, and 82.3% responded to the drug.
2) Clinical efficacy of MOM at a daily dose of 600 mg was 83.2% based on committee-judgement and 80.0% based on doctors' judgement.
3) MOM shows antibacterial activity against aerobes, anaerobes and mixed infection cases.
4) In 4 of the 160 cases treated, gastrointestinal symptoms were appeared.
5) From the above results, it was concluded that MOM was a useful new antibiotic for the treatment of oral infections.
